tiprankstipranks
Conmed (CNMD)
NYSE:CNMD
US Market

Conmed (CNMD) Income Statement

Compare
187 Followers

Conmed Income Statement

Last quarter (Q3 2024), Conmed's total revenue was $316.70M, an increase of 3.98% from the same quarter last year. In Q3, Conmed's net income was $48.98M. See Conmed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.31B$ 1.24B$ 1.05B$ 1.01B$ 862.46M
Gross Profit
$ 1.31B$ 676.25M$ 571.25M$ 568.04M$ 460.30M
Operating Expenses
$ 237.23M$ 555.64M$ 501.19M$ 458.32M$ 414.29M
Depreciation and Amortization
$ 0.00$ 51.40M$ 49.76M$ 49.79M$ 52.24M
EBITDA
$ 0.00$ 192.48M$ 7.80M$ 158.38M$ 113.58M
Operating Income
$ 1.07B$ 130.79M$ 70.05M$ 37.85M$ -26.97M
Other Income/Expenses
$ -906.76M$ -49.96M$ -140.92M$ -36.61M$ -44.41M
Pretax Income
$ 163.03M$ 80.83M$ -70.86M$ 73.11M$ 1.60M
Net Income
$ 132.42M$ 64.46M$ -80.58M$ 62.54M$ 9.52M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 4.29$ 2.10$ -2.68$ 2.14$ 0.33
Diluted EPS
$ 4.26$ 2.04$ -2.68$ 1.94$ 0.32
Weighted Average Shares Outstanding
30.86M 30.67M 30.04M 29.16M 28.58M
Weighted Average Shares Outstanding (Diluted)
31.11M 31.55M 30.04M 32.22M 29.46M
Currency in USD

Conmed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis